Madrigal Pharmaceuticals (MDGL) Q4 2023 Earnings

28FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-5.68
-5.2
-4.71
-4.23

Details

Expected EPS
-5.238808
Actual EPS
-5.68
Surprise EPS
-0.44
Surprise Percent
+8.42%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -5.68 per share for Q4 2023.

0 Comments

Share your thoughts